Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sinn

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|October 15, 2014
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 studyM Sinn, C Denkert, J K Striefler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2015
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialM Sinn, H Riess, B V Sinn, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|November 14, 2014
Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recoverySteffi Hoppe, Christian von Loeffelholz, Johan F Lock, et al.
Pancreas|November 26, 2014
Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survivalCarsten Kamphues, Roberta Bova, Marcus Bahra, et al.
Histopathology|March 6, 2012
High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancerFrederick Klauschen, Moritz von Winterfeld, Albrecht Stenzinger, et al.
Pathology, Research and Practice|July 28, 2016
P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatmentJana K Striefler, Marianne Sinn, Uwe Pelzer, et al.
British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.
Journal of Surgical Oncology|September 17, 2013
Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 studyMarianne Sinn, Jana K Striefler, Bruno V Sinn, et al.
Histopathology|June 16, 2010
Expression of classical NF-kappaB pathway effectors in human ovarian carcinomaSilvia Darb-Esfahani, Bruno V Sinn, Wilko Weichert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Sven Bischoff, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|October 15, 2014
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 studyM Sinn, C Denkert, J K Striefler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2015
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialM Sinn, H Riess, B V Sinn, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|November 14, 2014
Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recoverySteffi Hoppe, Christian von Loeffelholz, Johan F Lock, et al.
Pancreas|November 26, 2014
Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survivalCarsten Kamphues, Roberta Bova, Marcus Bahra, et al.
Histopathology|March 6, 2012
High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancerFrederick Klauschen, Moritz von Winterfeld, Albrecht Stenzinger, et al.
Pathology, Research and Practice|July 28, 2016
P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatmentJana K Striefler, Marianne Sinn, Uwe Pelzer, et al.
British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.
Journal of Surgical Oncology|September 17, 2013
Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 studyMarianne Sinn, Jana K Striefler, Bruno V Sinn, et al.
Histopathology|June 16, 2010
Expression of classical NF-kappaB pathway effectors in human ovarian carcinomaSilvia Darb-Esfahani, Bruno V Sinn, Wilko Weichert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2017
Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Sven Bischoff, et al.
Pageof 6